Cogent Biosciences
COGT
#2688
Rank
ยฃ4.64 B
Marketcap
ยฃ30.23
Share price
3.95%
Change (1 day)
298.59%
Change (1 year)

Revenue for Cogent Biosciences (COGT)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cogent Biosciences from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 ยฃ5.77 M-66.34%
2019 ยฃ17.15 M123.74%
2018 ยฃ7.66 M23.97%
2017 ยฃ6.18 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
ยฃ0.16 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.48 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA